2Indexed trials
drug · Product Intelligence
Ofatumumab
Pipeline Intelligence
Ofatumumab: 2 indexed trials, 2 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.
2Sponsors
0Orange Book patent links
0FDA-linked events
Development evidence
NCT04510220Brigham and Women's Hospital · multiple_sclerosisPHASE3
NCT06251986Novartis Pharmaceuticals · multiple_sclerosisCOMPLETED
FDA / patent evidence
No FDA Orange Book product match is asserted for this intervention.
Regulatory context
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.